Large animal induced pluripotent stem cells as pre-clinical models for studying human disease

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 6, 2012, Pages 1196-1202

  Plews, Jordan R ^a   Gu, Mingxia ^a   Longaker, Michael T ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bovine; Canine; Disease modelling; Induced pluripotent stem cells; Large animal iPS; Porcine; Primate

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; DISEASE MODEL; EMBRYONIC STEM CELL; HUMAN; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

ANIMALIA; BOVINAE; IPS; PRIMATES; SUS;

EID: 84861563471     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01521.x     Document Type: Review

References (56)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145-7.
2. Munn D. Moral issues of human embryo research. Science. 2001; 293: 211.
3. Cowan CA, Atienza J, Melton DA, et al. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science. 2005; 309: 1369-73.
4. Matsumura H, Tada T. Cell fusion-mediated nuclear reprogramming of somatic cells. Reprod Biomed Online. 2008; 16: 51-6.
5. Flasza M, Shering AF, Smith K, et al. Reprogramming in inter-species embryonal carcinoma-somatic cell hybrids induces expression of pluripotency and differentiation markers. Cloning Stem Cells. 2003; 5: 339-54.
6. Hakelien AM, Gaustad KG, Collas P. Modulation of cell fate using nuclear and cytoplasmic extracts. Methods Mol Biol. 2006; 325: 99-114.
7. Collas P, Taranger CK. Epigenetic reprogramming of nuclei using cell extracts. Stem Cell Rev. 2006; 2: 309-17.
8. Taranger CK, Noer A, Sorensen AL, et al. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell. 2005; 16: 5719-35.
9. Li J, Liu X, Wang H, et al. Human embryos derived by somatic cell nuclear transfer using an alternative enucleation approach. Cloning Stem Cells. 2009; 11: 39-50.
10. Briggs R, King TJ. Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc Natl Acad Sci USA. 1952; 38: 455-63.
11. Gurdon JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol. 1962; 10: 622-40.
12. Wilmut I, Schnieke AE, McWhir J, et al. Viable offspring derived from foetal and adult mammalian cells. Nature. 1997; 385: 810-3.
13. Levens ED, DeCherney AH. Human oocyte research: the ethics of donation and donor protection. JAMA. 2008; 300: 2174-6.
14. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-76.
15. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448: 313-7.
16. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861-72.
17. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007; 448: 318-24.
18. Zhao XY, Li W, Lv Z, et al. iPS cells produce viable mice through tetraploid complementation. Nature. 2009; 461: 86-90.
19. Kang L, Wang J, Zhang Y, et al. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell. 2009; 5: 135-8.
20. Boland MJ, Hazen JL, Nazor KL, et al. Adult mice generated from induced pluripotent stem cells. Nature. 2009; 461: 91-4.
21. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318: 1917-20.
22. Han X, Han J, Ding F, et al. Generation of induced pluripotent stem cells from bovine embryonic fibroblast cells. Cell Res. 2011; 21: 1509-12.
23. Liao J, Cui C, Chen S, et al. Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell. 2009; 4: 11-5.
24. Ezashi T, Telugu BP, Alexenko AP, et al. Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci USA. 2009; 106: 10993-8.
25. Esteban MA, Xu J, Yang J, et al. Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem. 2009; 284: 17634-40.
26. Zhong B, Trobridge GD, Zhang X, et al. Efficient generation of nonhuman primate induced pluripotent stem cells. Stem Cells Dev. 2011; 20: 795-807.
27. West FD, Terlouw SL, Kwon DJ, et al. Porcine induced pluripotent stem cells produce chimeric offspring. Stem Cells Dev. 2010; 19: 1211-20.
28. Li Y, Cang M, Lee AS, et al. Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors. PLoS ONE. 2011; 6: e15947.
29. Shimada H, Nakada A, Hashimoto Y, et al. Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol Reprod Dev. 2010; 77: 2.
30. Lee AS, Xu D, Plews JR, et al. Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells. J Biol Chem. 2011; 286: 32697-704.
31. Friedrich Ben-Nun I, Montague SC, Houck ML, et al. Induced pluripotent stem cells from highly endangered species. Nat Methods. 2011; 8: 829-31.
32. Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007; 318: 1920-3.
33. Xu D, Alipio Z, Fink LM, et al. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci USA. 2009; 106: 808-13.
34. Alipio Z, Liao W, Roemer EJ, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci USA. 2010; 107: 13426-31.
35. Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the foetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA. 2008; 105: 5856-61.
36. Narsinh K, Narsinh KH, Wu JC, et al. Derivation of human induced pluripotent stem cells for cardiovascular disease modelling. Circ Res. 2011; 108: 1146-56.
37. Suo J, Ferrara DE, Sorescu D, et al. Hemodynamic shear stresses in mouse aortas: implications for atherogenesis. Arterioscler Thromb Vasc Biol. 2007; 27: 346-51.
38. Lowey S, Lesko LM, Rovner AS, et al. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone. J Biol Chem. 2008; 283: 20579-89.
39. Liu H, Zhu F, Yong J, et al. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell. 2008; 3: 587-90.
40. Zhu FF, Zhang PB, Zhang DH, et al. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells. Diabetologia. 2011; 54: 2325-36.
41. Zhong B, Watts KL, Gori JL, et al. Safeguarding nonhuman primate iPS cells with suicide genes. Mol Ther. 2011; 19: 1667-75.
42. Hall V. Porcine embryonic stem cells: a possible source for cell replacement therapy. Stem Cell Rev. 2008; 4: 275-82.
43. Chen LR, Shiue YL, Bertolini L, et al. Establishment of pluripotent cell lines from porcine preimplantation embryos. Theriogenology. 1999; 52: 195-212.
44. Li M, Zhang D, Hou Y, et al. Isolation and culture of embryonic stem cells from porcine blastocysts. Mol Reprod Dev. 2003; 65: 429-34.
45. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA. 1981; 78: 7634-8.
46. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292: 154-6.
47. Ying QL, Nichols J, Chambers I, et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell. 2003; 115: 281-92.
48. Hayes B, Fagerlie SR, Ramakrishnan A, et al. Derivation, characterization, and in vitro differentiation of canine embryonic stem cells. Stem Cells. 2008; 26: 465-73.
49. Hatoya S, Torii R, Kondo Y, et al. Isolation and characterization of embryonic stem-like cells from canine blastocysts. Mol Reprod Dev. 2006; 73: 298-305.
50. Schneider MR, Adler H, Braun J, et al. Canine embryo-derived stem cells-toward clinically relevant animal models for evaluating efficacy and safety of cell therapies. Stem Cells. 2007; 25: 1850-1.
51. Roberts RM, Telugu BP, Ezashi T. Induced pluripotent stem cells from swine (Sus scrofa): why they may prove to be important. Cell Cycle. 2009; 8: 3078-81.
52. Ezashi T, Matsuyama H, Telugu BP, et al. Generation of colonies of induced trophoblast cells during standard reprogramming of porcine fibroblasts to induced pluripotent stem cells. Biol Reprod. 2011; 85: 779-87.
53. Baker DE, Harrison NJ, Maltby E, et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol. 2007; 25: 207-15.
54. Draper JS, Smith K, Gokhale P, et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol. 2004; 22: 53-4.
55. Aasen T, Raya A, Barrero MJ, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol. 2008; 26: 1276-84.
56. Wu Z, Chen J, Ren J, et al. Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol. 2009; 1: 46-54.